ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
132.344,88
0,30%
S&P 500
5.667,56
0,08%
US Dollar vs BRL
5,7351
0,00%
Bitcoin
84.208,63
0,19%
Brent Oil
71,775
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) Notícias

AGY

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:AGY
DataHoraFonteTítuloCódigoCompanhia
03/03/202504:00RNS Regulatory NewsAllergy Therapeutics PLC New Executive Long Term Incentive AwardsLSE:AGYAllergy Therapeutics Plc
27/02/202504:00RNS Non-RegulatoryAllergy Therapeutics PLC Presentations at 2025 AAAAI / WAO Joint CongressLSE:AGYAllergy Therapeutics Plc
17/02/202504:00RNS Regulatory NewsAllergy Therapeutics PLC Grass MATA MPL Phase III data published in AllergyLSE:AGYAllergy Therapeutics Plc
14/02/202504:00RNS Regulatory NewsAllergy Therapeutics PLC Grant of OptionsLSE:AGYAllergy Therapeutics Plc
28/01/202518:19Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics expects annual sales to rise on-yearLSE:AGYAllergy Therapeutics Plc
28/01/202504:00RNS Regulatory NewsAllergy Therapeutics PLC Half Year Trading updateLSE:AGYAllergy Therapeutics Plc
22/01/202504:00RNS Regulatory NewsAllergy Therapeutics PLC PDMR Dealing and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
15/01/202504:00RNS Regulatory NewsAllergy Therapeutics PLC Director/PDMR ShareholdingLSE:AGYAllergy Therapeutics Plc
19/12/202410:41RNS Regulatory NewsAllergy Therapeutics PLC Exercise of Options and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
17/12/202413:19RNS Regulatory NewsAllergy Therapeutics PLC Block Listing Interim ReviewLSE:AGYAllergy Therapeutics Plc
16/12/202412:33RNS Regulatory NewsAllergy Therapeutics PLC Result of Annual General MeetingLSE:AGYAllergy Therapeutics Plc
04/12/202404:00RNS Regulatory NewsAllergy Therapeutics PLC Positive Interim Data from PROTECT TrialLSE:AGYAllergy Therapeutics Plc
27/11/202413:52Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics treats first patient in allergy trialLSE:AGYAllergy Therapeutics Plc
27/11/202404:00RNS Regulatory NewsAllergy Therapeutics PLC First Patient Dosed in G308 Paediatric TrialLSE:AGYAllergy Therapeutics Plc
25/11/202404:00RNS Regulatory NewsAllergy Therapeutics PLC Submission of MAA for Grass MATA MPLLSE:AGYAllergy Therapeutics Plc
21/11/202404:00RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2024 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
06/11/202408:22Alliance NewsAlliance NewsAllergy Therapeutics annual loss narrows thanks to reduced expensesLSE:AGYAllergy Therapeutics Plc
06/11/202404:00RNS Regulatory NewsAllergy Therapeutics PLC Audited Preliminary Results 2024LSE:AGYAllergy Therapeutics Plc
21/10/202406:56Alliance NewsAlliance NewsAllergy Therapeutics enrols candidates for grass pollen allergy trialLSE:AGYAllergy Therapeutics Plc
21/10/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Commencement of Phase III Paediatric TrialLSE:AGYAllergy Therapeutics Plc
16/10/202406:58Alliance NewsAlliance NewsAllergy Therapeutics shares surge as enters into secured loan facilityLSE:AGYAllergy Therapeutics Plc
16/10/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
01/10/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Update on funding and preliminary resultsLSE:AGYAllergy Therapeutics Plc
17/09/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Progression of patient cohorts in PROTECT TrialLSE:AGYAllergy Therapeutics Plc
27/08/202405:57Alliance NewsAlliance NewsAllergy Therapeutics secures cash to see it through SeptemberLSE:AGYAllergy Therapeutics Plc
22/07/202412:26Alliance NewsAlliance NewsTRADING UPDATES: Croma Security trading well; Fonix to up final payoutLSE:AGYAllergy Therapeutics Plc
22/07/202403:01RNS Regulatory NewsAllergy Therapeutics PLC Trading update for the year ended 30 June 2024LSE:AGYAllergy Therapeutics Plc
22/07/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Nominated Adviser and Sole BrokerLSE:AGYAllergy Therapeutics Plc
04/07/202410:22RNS Regulatory NewsAllergy Therapeutics PLC Launch of new Company Long Term Incentive PlanLSE:AGYAllergy Therapeutics Plc
27/06/202403:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Non-Executive DirectorLSE:AGYAllergy Therapeutics Plc
 Apresentando as notícias mais relevantes sobre:LSE:AGY

Seu Histórico Recente

NYSE
GLW
Corning
NYSE
WPP
WPP
NYSE
STN
Stantec
NYSE
PPL
PPL
NYSE
APH
Amphenol
EU
CDCJJ
Fund deposits and Consig...
NYSE
CCS
Century Communities
LSE
CTY
City Of London Investment
TSX
DCM
Data Communications Mana...
TG
OMVD
OMV
FTSE
E3X451020
FTSEurofirst 300 Food Pr...
Delayed Upgrade Clock
ADVFN Logo
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios